Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
777P A prospective, single-arm, open-label study of camrelizumab, apatinib and nab-paclitaxel in patients with advanced cervical cancer
Home
Publications
777P A prospective, single-arm, open-label study of camrelizumab, apatinib and nab-paclitaxel in patients with advanced cervical cancer
777P A prospective, single-arm, open-label study of camrelizumab, apatinib and nab-paclitaxel in patients with advanced cervical cancer
Authors:
GL
G. Li
G. Li
YZ
Y. Zhao
Y. Zhao
YJ
Y. Jiang
Y. Jiang
QY
Q. Yang
Q. Yang
AH
A. Huang
A. Huang
YC
Y. Chen
Y. Chen
DH
D. Han
D. Han
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
1 September 2021
journal article
abstracts
Published by
Elsevier
in
Annals of Oncology
Vol. 32
,
S753-S754
DOI:
10.1016/j.annonc.2021.08.1219
Abstract
No abstract available
Keywords
APATINIB
NAB-PACLITAXEL
OPEN LABEL
Cited
Cited by 1 article
Scroll to top